AstraZeneca/ Oxford resumes the trial of their COVID-19 vaccine in the UK
After receiving a go-ahead from the UK’s Medicines Health Regulatory Authority, AstraZeneca and the University of Oxford have resumed the trials of their experimental coronavirus candidate AZD1222 in the country. A rapid review by the trial’s independent safety review committee and national regulators has stamped upon the safety and efficacy of the vaccine needed to proceed further. However, the studies in the US remains halted.
The duo had to suspend the trials a week ago after a patient got critically ill. The company still has not disclosed any further information and labelled the condi...
